Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
In the latest session, Hims & Hers Health Inc (NYSE: HIMS) closed at $11.26 down -8.01% from its previous closing price of $12.24. In other words, the price has decreased by -$8.01 from its previous closing price. On the day, 11.97 million shares were traded. HIMS stock price reached its highest trading level at $12.37 during the session, while it also had its lowest trading level at $11.2.
Ratios:
For a deeper understanding of Hims & Hers Health Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 10.92 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 51.34. For the most recent quarter (mrq), Quick Ratio is recorded 2.74 and its Current Ratio is at 3.00. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Jefferies on April 16, 2024, Downgraded its rating to Hold and sets its target price to $15 from $17 previously.
On April 10, 2024, Canaccord Genuity started tracking the stock assigning a Buy rating and target price of $20.
Imperial Capital Upgraded its In-line to Outperform on February 28, 2024, while the target price for the stock was maintained at $16.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on May 03 ’24 when Baird Melissa sold 11,750 shares for $11.64 per share. The transaction valued at 136,826 led to the insider holds 538,932 shares of the business.
Baird Melissa sold 11,750 shares of HIMS for $141,923 on May 02 ’24. The Chief Operating Officer now owns 538,932 shares after completing the transaction at $12.08 per share. On May 01 ’24, another insider, Dudum Andrew, who serves as the Chief Executive Officer of the company, sold 188,888 shares for $12.54 each. As a result, the insider received 2,367,891 and left with 0 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HIMS now has a Market Capitalization of 2416947712 and an Enterprise Value of 2201425408. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.77 while its Price-to-Book (P/B) ratio in mrq is 6.99. Its current Enterprise Value per Revenue stands at 2.525 whereas that against EBITDA is -133.476.
Stock Price History:
Over the past 52 weeks, HIMS has reached a high of $17.16, while it has fallen to a 52-week low of $5.65. The 50-Day Moving Average of the stock is -18.73%, while the 200-Day Moving Average is calculated to be 21.96%.
Shares Statistics:
For the past three months, HIMS has traded an average of 5.27M shares per day and 3797190 over the past ten days. A total of 205.10M shares are outstanding, with a floating share count of 138.86M. Insiders hold about 34.85% of the company’s shares, while institutions hold 38.57% stake in the company. Shares short for HIMS as of 1713139200 were 17468335 with a Short Ratio of 3.31, compared to 1710460800 on 12762013. Therefore, it implies a Short% of Shares Outstanding of 17468335 and a Short% of Float of 9.29.
